RECRUITINGOBSERVATIONAL
Altshock-2 REGISTRY
Cardiogenic Shock: a Prospective National Registry to Get Insights in Patients' Profile, Management and Outcome
About This Trial
The study will provide data on profile, management, outcome, and evolution over time of cardiogenic shock patients admitted to the Intensive Coronary Care Units
Who May Be Eligible (Plain English)
All consecutive CS patients hospitalized in the above reported centres between January 2020 and December 2030.
Cardiogenic shock is defined as:
1. Systolic blood pressure (SBP) \<90 mmHg or mean arterial pressure (MAP) \<60 mmHg, after an appropriate fluid challenge if there is no sign of overt fluid overload, OR need of vasoactive agents to maintain SBP \> 90 mmHg or MAP \> 60 mmHg, OR need of MCS;
2. At least one of the following criteria/signs of overt hypoperfusion: mixed venous oxygen saturation \<60%; arterial lactates \> 2 mmol/L; oliguria \< 0.5 ml/Kg/h for at least 6 hours.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
All consecutive CS patients hospitalized in the above reported centres between January 2020 and December 2030.
Cardiogenic shock is defined as:
1. Systolic blood pressure (SBP) \<90 mmHg or mean arterial pressure (MAP) \<60 mmHg, after an appropriate fluid challenge if there is no sign of overt fluid overload, OR need of vasoactive agents to maintain SBP \> 90 mmHg or MAP \> 60 mmHg, OR need of MCS;
2. At least one of the following criteria/signs of overt hypoperfusion: mixed venous oxygen saturation \<60%; arterial lactates \> 2 mmol/L; oliguria \< 0.5 ml/Kg/h for at least 6 hours.
Locations (1)
ASST GOM Niguarda
Milan, Italy